Nanobiotix SA
LSE:0QAV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nanobiotix SA
LSE:0QAV
|
FR |
|
C
|
China Taiping Insurance Holdings Co Ltd
XMUN:HIUC
|
HK |
|
O
|
OPKO Health Inc
BMV:OPK
|
US |
|
Synergie SE
PAR:SDG
|
FR |
|
Archi Indonesia Tbk PT
IDX:ARCI
|
ID |
|
T
|
Telkom Indonesia (Persero) Tbk PT
XMUN:TCID
|
ID |
|
O
|
Oil and Gas Development Co Ltd
KAR:OGDC
|
PK |
|
F
|
Freehold Royalties Ltd
LSE:0UWL
|
CA |
|
S
|
Societe Generale SA
XHAN:SGE
|
FR |
|
T
|
Thai Union Feedmill PCL
SET:TFM
|
TH |
Wall St Price Targets
0QAV Price Targets Summary
Nanobiotix SA
According to Wall Street analysts, the average 1-year price target for
0QAV is 48.85 EUR with a low forecast of 34.38 EUR and a high forecast of 63.08 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0QAV's stock price target?
Price Target
48.85
EUR
According to Wall Street analysts, the average 1-year price target for
0QAV is 48.85 EUR with a low forecast of 34.38 EUR and a high forecast of 63.08 EUR.
What is the Revenue forecast for Nanobiotix SA?
Projected CAGR
74%
Over the last 14 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 8 years is 74%.